Influence of sufentanil infusion on remifentanil based anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000785

Enrollment

120

Registered

2013-07-09

Start date

2013-06-27

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After procuration of surgical specimen, sufentanil (S group) or normal saline (C group) will be infused intravenously at target concentration 0.15 ng/ml until extubation. The 50 ml syringe fill

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing gynaecologic laparoscopic surgery with intravenous patient controlled analgesia (PCA) for postoperative pain control were enrolled. The patients were American Society of Anesthesiologists Patient Status (ASA PS) I or II, and at least 20 years old

Exclusion criteria

Exclusion criteria: 1) urgent or emergent case 2) re-do case 3) allergy to egg or soybean oil 4) QT prolongation in preoperative electrocardiography 5) history of drug abuse 6) receiving current medications 7) concurrent other surgery 8) surgery within 1 hour 9) discharge within 72 hours

Design outcomes

Primary

Measure	Time frame
pain score via Visual Analog Scale;mean blood pressure, heart rate	—

Secondary

Measure	Time frame
post operative nausea and vomiting	—

Countries

Korea, Republic of

Contacts

Public ContactChung-Sik Oh

Konkuk University Medical Center

ohcsik@daum.net+82-2-2030-5457

Outcome results